{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T01:00:35Z","timestamp":1759366835127,"version":"build-2065373602"},"reference-count":12,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,4,25]],"date-time":"2025-04-25T00:00:00Z","timestamp":1745539200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinical-lung-cancer.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Lung Cancer"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.cllc.2025.04.013","type":"journal-article","created":{"date-parts":[[2025,4,28]],"date-time":"2025-04-28T19:11:28Z","timestamp":1745867488000},"page":"e409-e412","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Multiple Sclerosis and Lung Cancer: A Single Cancer Center Experience in Philadelphia"],"prefix":"10.1016","volume":"26","author":[{"given":"Julia","family":"Palecki","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthew","family":"Tucker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew","family":"Bernstein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Garrett","family":"Melby","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tingting","family":"Zhan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0871-7802","authenticated-orcid":false,"given":"Ida","family":"Micaily","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cllc.2025.04.013_bib0001","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.msard.2017.07.020","article-title":"Smoking and multiple sclerosis: a systematic review and meta-analysis using the Bradford Hill criteria for causation","volume":"17","author":"Degelman","year":"2017","journal-title":"Mult Scler Relat Disord"},{"issue":"1","key":"10.1016\/j.cllc.2025.04.013_bib0002","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/ene.13819","article-title":"Multiple sclerosis\u2014a review","volume":"26","author":"Dobson","year":"2019","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.cllc.2025.04.013_bib0003","doi-asserted-by":"crossref","first-page":"102927","DOI":"10.1016\/j.msard.2021.102927","article-title":"Lung cancer risk in patients with multiple sclerosis: a mendelian randomization analysis","volume":"51","author":"Ge","year":"2021","journal-title":"Mult Scler Relat Disord"},{"key":"10.1016\/j.cllc.2025.04.013_bib0004","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.msard.2019.08.005","article-title":"Risk of cancer among Finnish multiple sclerosis patients","volume":"35","author":"Hongell","year":"2019","journal-title":"Mult Scler Relat Disord"},{"issue":"9","key":"10.1016\/j.cllc.2025.04.013_bib0005","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.0000000000209885","article-title":"Cancer risk among patients with multiple sclerosis: a 10-year nationwide retrospective cohort study","volume":"103","author":"Pierret","year":"2024","journal-title":"Neurology"},{"issue":"4","key":"10.1016\/j.cllc.2025.04.013_bib0006","doi-asserted-by":"crossref","first-page":"962","DOI":"10.55730\/1300-0144.5660","article-title":"Is cancer risk reduced in multiple sclerosis? Results from a tertiary referral center","volume":"53","author":"Bahar","year":"2023","journal-title":"Turk J Med Sci"},{"issue":"8","key":"10.1016\/j.cllc.2025.04.013_bib0007","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1093\/qjmed\/hcq071","article-title":"Multiple sclerosis and lung cancer: an unexpected inverse association","volume":"103","author":"Handel","year":"2010","journal-title":"QJM: An Int J Med"},{"key":"10.1016\/j.cllc.2025.04.013_bib0008","doi-asserted-by":"crossref","first-page":"2954","DOI":"10.3389\/fimmu.2019.02954","article-title":"Multiple sclerosis and cancer: the Ying-Yang effect of disease modifying therapies","volume":"10","author":"Melamed","year":"2019","journal-title":"Front Immunol"},{"issue":"1","key":"10.1016\/j.cllc.2025.04.013_bib0009","doi-asserted-by":"crossref","first-page":"12533","DOI":"10.1038\/s41598-021-91912-x","article-title":"Potential risk of disease modifying therapies on neoplasm development and coadjutant factors in multiple sclerosis outpatients","volume":"11","author":"Gil-Bernal","year":"2021","journal-title":"Sci Rep"},{"issue":"7","key":"10.1016\/j.cllc.2025.04.013_bib0010","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1007\/s00415-011-5929-9","article-title":"Cancer and multiple sclerosis in the era of disease-modifying treatments","volume":"258","author":"Lebrun","year":"2011","journal-title":"J Neurol"},{"issue":"1","key":"10.1016\/j.cllc.2025.04.013_bib0011","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1186\/s12883-017-0932-0","article-title":"Association between multiple sclerosis, cancer risk, and immunosuppressant treatment: a cohort study","volume":"17","author":"Ragonese","year":"2017","journal-title":"BMC Neurol"},{"issue":"8","key":"10.1016\/j.cllc.2025.04.013_bib0012","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1093\/annonc\/mdz167","article-title":"Immune checkpoint inhibitors of patients with advanced lung cancer and oncogenic driver alterations: results from the IMMUNOTARGET registry","volume":"30","author":"Mazieres","year":"2019","journal-title":"Ann Oncol"}],"container-title":["Clinical Lung Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525730425000865?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525730425000865?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T20:44:10Z","timestamp":1759351450000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525730425000865"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":12,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,9]]}},"alternative-id":["S1525730425000865"],"URL":"https:\/\/doi.org\/10.1016\/j.cllc.2025.04.013","relation":{},"ISSN":["1525-7304"],"issn-type":[{"type":"print","value":"1525-7304"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Multiple Sclerosis and Lung Cancer: A Single Cancer Center Experience in Philadelphia","name":"articletitle","label":"Article Title"},{"value":"Clinical Lung Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cllc.2025.04.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}